Study identity card

Sander

Germany
Share
  • Disease: Mpox
  • Study type: Observational Cohort Study, Prevention
  • Study type descriptors: Prospective, Multicentre
  • Objective: To assess the safety and effectiveness of MVA-BN vaccination against mpox infection in at-risk individuals in Germany
  • Number of participants enrolled: 15813
  • Study enrolling from to
  • Study includes follow-up for 1 year

Study Data

  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Other information

Funders/Sponsors:

  • Charité, Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Infektiologie und Pneumologie

The information was provided with the aid of the study investigators

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to